JPS61158989A - 有機ゲルマニウム化合物 - Google Patents
有機ゲルマニウム化合物Info
- Publication number
- JPS61158989A JPS61158989A JP59281001A JP28100184A JPS61158989A JP S61158989 A JPS61158989 A JP S61158989A JP 59281001 A JP59281001 A JP 59281001A JP 28100184 A JP28100184 A JP 28100184A JP S61158989 A JPS61158989 A JP S61158989A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- present
- germanium
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Organogermanium compound Chemical class 0.000 title abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 38
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract description 9
- 229910052732 germanium Inorganic materials 0.000 abstract description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 229940093626 germanium sesquioxide Drugs 0.000 abstract description 2
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 6
- 150000002291 germanium compounds Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000001490 Opioid Peptides Human genes 0.000 description 3
- 108010093625 Opioid Peptides Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000000593 degrading effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960005181 morphine Drugs 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003399 opiate peptide Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000005704 oxymethylene group Chemical group [H]C([H])([*:2])O[*:1] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical group O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59281001A JPS61158989A (ja) | 1984-12-29 | 1984-12-29 | 有機ゲルマニウム化合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59281001A JPS61158989A (ja) | 1984-12-29 | 1984-12-29 | 有機ゲルマニウム化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61158989A true JPS61158989A (ja) | 1986-07-18 |
| JPS6332359B2 JPS6332359B2 (enrdf_load_stackoverflow) | 1988-06-29 |
Family
ID=17632883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59281001A Granted JPS61158989A (ja) | 1984-12-29 | 1984-12-29 | 有機ゲルマニウム化合物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61158989A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0548230U (ja) * | 1991-11-29 | 1993-06-25 | 第一電子工業株式会社 | 表面実装用コネクタ |
| US6451850B1 (en) | 1998-08-17 | 2002-09-17 | Evgeny Vladimirovich Soloviev | Bio-chemical germanium complexes with high therapeutic efficiency and wide application spectrum |
-
1984
- 1984-12-29 JP JP59281001A patent/JPS61158989A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0548230U (ja) * | 1991-11-29 | 1993-06-25 | 第一電子工業株式会社 | 表面実装用コネクタ |
| US6451850B1 (en) | 1998-08-17 | 2002-09-17 | Evgeny Vladimirovich Soloviev | Bio-chemical germanium complexes with high therapeutic efficiency and wide application spectrum |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6332359B2 (enrdf_load_stackoverflow) | 1988-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0166366B1 (en) | Novel platinum complexes | |
| Serroni et al. | New procedures for the synthesis of mixed-metal and/or mixed-ligand ruthenium (II) and osmium (II) polypyridine supramolecules and the use of these procedures in the preparation of hexanuclear species | |
| Rousselle et al. | Development of a novel highly anti-proliferative family of gold complexes: Au (i)-phosphonium-phosphines | |
| EP0115929A1 (en) | Novel organic platinum complex and process for the preparation thereof | |
| EP0176005B1 (en) | Novel platinum complexes | |
| CA1251203A (en) | Amino-anthracenediones-platinum complexes useful as anti-cancer compounds | |
| GB2143128A (en) | Antineoplastic organogermanium compounds | |
| JPS61158989A (ja) | 有機ゲルマニウム化合物 | |
| EP0457921B1 (en) | Novel platinum (ii) complex and drug for treating malignant tumor | |
| US4994591A (en) | Platinum complexes derived from b-silyamines | |
| Li et al. | Formation of a Novel Amidinium‐Bridged Polyhedral Borane Ion by Incorporation of an Acetonitrile Solvent Molecule | |
| US8283473B2 (en) | Platinum complex compound and utilization of the same | |
| CN116253763A (zh) | 氧化异阿朴菲生物碱的n-杂环卡宾类金属有机钯配合物及其合成方法和应用 | |
| EP0518645B1 (en) | Platinum (II) complex and antitumor agent | |
| Xu et al. | Synthesis and characterization of heterobimetallic complexes with bridging acyl groups:(CO) 4Fe (. mu.-C (R) O) M (CO) 4 (R= Ph, Me; M= Re, Mn) | |
| GB2134103A (en) | Novel organic platinum complex and process for the preparation thereof | |
| Khasnis et al. | The first nitrogen-only-bonded metal derivatives of cyclenphosphorane. Formation of cyclenPH. cntdot. MCl2 and cyclenPH. cntdot. HMCl3 (M= zinc, cadmium) | |
| Berg et al. | A binuclear copper (II) complex with a bridging thioether ligand. Crystal and molecular structure of dicopper (thiobis (ethylenenitrilo) tetraacetate) pentahydrate | |
| WO1995028408A1 (fr) | Nouveau complexe de platine (ii) et medicament contre les tumeurs malignes | |
| EP0310260A2 (en) | Platinum complexes and their use as anti-tumor agents | |
| Tierney et al. | Stereochemical preferences of methyl-substituted piperazines chelated to platinum (II) | |
| JPH0583558B2 (enrdf_load_stackoverflow) | ||
| JPS61148185A (ja) | 有機ゲルマニウム化合物の製造方法 | |
| CA1256115A (en) | Platinum complexes | |
| JPS6292A (ja) | 有機ゲルマニウム化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |